| Literature DB >> 35884088 |
Erika Alejandra Jardón-Romero1, Edith Lara-Carrillo1, María G González-Pedroza2, Víctor Sánchez-Mendieta3, Elías Nahum Salmerón-Valdés4, Víctor Hugo Toral-Rizo4, Oscar F Olea-Mejía3, Saraí López-González1, Raúl A Morales-Luckie4.
Abstract
Syzygium aromaticum (clove) has been used as a dental analgesic, an anesthetic, and a bioreducing and capping agent in the formation of metallic nanoparticles. The main objective of this study was to evaluate the antimicrobial effect in oral microorganisms of biogenic silver nanoparticles (AgNPs) formed with aqueous extract of clove through an ecofriendly method "green synthesis". The obtained AgNPs were characterized by UV-Vis (ultraviolet-visible spectroscopy), SEM-EDS (scanning electron microscopy-energy dispersive X-ray spectroscopy), TEM (transmission electron microscopy), and ζ potential, while its antimicrobial effect was corroborated against oral Gram-positive and Gram-negative microorganisms, as well as yeast that is commonly present in the oral cavity. The AgNPs showed absorption at 400-500 nm in the UV-Vis spectrum, had an average size of 4-16 nm as observed by the high-resolution transmission electron microscopy (HR-TEM), and were of a crystalline nature and quasi-spherical form. The antimicrobial susceptibility test showed inhibition zones of 2-4 mm in diameter. Our results suggest that AgNPs synthesized with clove can be used as effective growth inhibitors in several oral microorganisms.Entities:
Keywords: Syzygium aromaticum; biosynthesis; oral microorganisms; silver nanoparticles
Year: 2022 PMID: 35884088 PMCID: PMC9311661 DOI: 10.3390/antibiotics11070834
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1UV-Vis absorption spectrum of synthesized silver nanoparticles by S. aromaticum extract at different time intervals.
Figure 2Scanning electron microscopy–energy dispersive X-ray spectrum of synthesized silver nanoparticles.
Figure 3Characterization of synthesized biogenic silver nanoparticles from clove extract. (A) Micrograph of transmission electron microscopy, the insert shows size distribution and (B) high-resolution transmission electron microscopy micrograph.
Figure 4Antimicrobial activity against: (A) Streptococcus mutans, (B) Staphylococcus aureus, (C) Escherichia coli, (D) Enterococcus faecalis, (E) Candida albicans. Disk 1, 24 h after synthesis; disk 2, 7 days after synthesis; disk 3, 14 days after synthesis; disk 4, 21 days after synthesis; disk 5, control disk only with clove extract.
Figure 5Microdilution in broth: (a) inhibition of microbial growth, (b) graph of antimicrobial growth against the applied concentration of nanoparticles.
Minimum inhibitory concentration and maximum effective concentration of silver nanoparticles.
| AgNPs | |||||
|---|---|---|---|---|---|
| AgNPs (mg/mL) |
|
|
|
|
|
| 0.849 | - | - | - | - | - |
| 0.425 | - | - | - | - |
|
| 0.212 | - | - | - |
| + |
| 0.106 | - |
| - | + | + |
| 0.053 | - | + |
| + | + |
| 0.026 | - | + | + | + | + |
| 0.013 |
| + | + | + | + |
| Control | + | + | + | + | + |
+ Microbial growth, - Without microbial growth MIC MEC .